Treatment of HCV positive individuals with normal serum ALT levels

Hepato-Gastroenterology

Volumn 45, Issue 20, 1998, Pages 321-324

  Van Thiel, David H ^a,b   Colantoni, Alessandra ^a   De Maria, Nicola ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Hepatitis C; IFN; Interferon; Normal ALT; Normal amino transferases

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT; RECOMBINANT ALPHA INTERFERON;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC HEPATITIS; HEPATITIS C; HUMAN; PRIORITY JOURNAL; SHORT SURVEY; SYMPTOM; VIRUS LOAD;

ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS;

EID: 0031980458     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (20)

1. Stevens CE, Taylor PE, Pindyck J, Choo QL, Bradley DW, Kuo G et al: Epidemiology of hepatitis C virus. A preliminary study in volunteer blood donors. JAMA 19990; 263:49-53.
2. Alter MJ, Margolis HS, Krawczynski K, Judson FN, Mares A, Alexander WJ et al: The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med 1992; 327:1899-905.
3. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ: Long-term clinical and histopathological follow-up of chronic post-transfusion hepatitis. Hepatology 1991: 14:969-74.
4. Gurakar A, Fagiuoli S, Wright HI, Van Thiel DH: Hepatitis C virus infection: When to suspect, how to detect. The Journal of Critical Illness 1993; 8:1287-1298.
5. Gurakar A, Fagiuoli S, Wright HI, Van Thiel DH: How and when to use interferon alfa to manage hepatitis C. Journal of Critical Illness 1994; 9:77-88.
6. Shakil AO, Conry-Cantilena C, Alter HJ, Hayashi P, Kleiner DE, Tedeschi V et al: Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group. Ann Intern Med 1995; 123:330-7.
7. Obald SA, Conry-Cantilena C, Alter HJ, Hayashi P, Kleiner DE, Tedeschi V, Krawczynski K, Conjeevaram HS, Sallie R, Di Bisceglie AM, Hepatitis C Study Group: Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. Ann Intern Med 1995; 123:330-337.
8. Idilman R, De Maria N, Colantoni A, Dokmeci A, Van Thiel DH: Interferon treatment of cirrhotic patients with chronic hepatitis C. Journal of Viral Hepatitis 1997; 4:00-00
9. Van Thiel DH, Gavaler JS, Baddour N, Friedlander L, Wright HI: Treatment of putative Non A, Non B, Non C hepatitis with -interferon: A preliminary trial. J Okla State Med Assoc 1994; 87
10. Friedlander L, Van Thiel DH, Faruki H, Molloy PJ, Kania RJ, Hassanein T: New approach to HCV treatment recognition of disease process as systemic viral infection rather than as liver disease. Digestive Diseases and Sciences 1996; 41:1678-1681.
11. Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, Goodman Z, Banks SM, Hoofnagel JH: Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N Eng J Med 1989; 321:1506-10.
12. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HCJ, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, Van Thiel DH, Tamburro C, Lefkowitch T, Albrecht J, Meschievitz C, Ortego T, Gibas A, The Hepatitis Interventional Therapy Group: Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. N Engl J Med 1989; 321:1501-6.
13. Naito M, Hayashi N, Hagiwara H, Hiramatsu N, Kasahara A, Fusamoto H et al: Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels. Hepatology 1994; 19:871-5.
14. Van Thiel DH, Caraceni P, Molloy PJ, Hassanein T, Kania RJ, Gurakar A, Nadir A, Friedlander L: Chronic hepatitis C in patients with normal or near normal alanine aminotransferase levels: The role of interferon 2b therapy. Journal of Hepatology 1995; 23:503-508.
15. Shindo M, Arai K, Sokawa Y, Okuno T: The virological and histological states of anti-hepatitis C virus-positive subjects with normal liver biochemical values. Hepatology 1995: 22:418-25.
16. Gholson CF, Faypot D, Taylor B, Catinis G, Balart L: Chronic hepatitis C virus (HCV) infection and persistently normal aminotransferases (PNAL): a preliminary report of alfa interferon (IFN) resistance. Hepatology 1996; 24:401A (Abstract 1097).
17. Rossini A, Ravaggi A, Biasi L, Callea F, Agostinelli E, Gazzola GB, Cariani E, Radaeli E: Virological response to interferon (IFN) treatment of HCV carriers with normal ALT. Hepatology 1996; 24:401A.
18. Curtiss JR, Herrera JL: Response to alpha interferon in patients with chronic hepatitis C and normal or near-normal ALT levels. Hepatology 1996; 24;401A.
19. Viladomiu L, Genesca J, Esteban JI, Allende H, Gonzalez A, Lopez-Talavera JC et al: Interferon-alpha in acute post-transfusion hepatitis C: a randomized, controlled trial. Hepatology 1992; 15:767-9.
20. Omata M, Yokosuka O, Takano S, Kato N, Hosoda K, Imazeki F et al: Resolution of acute hepatitis C after therapy with natural beta interferon. Lancet 1991; 338:914-5.